Entity Common Stock, Shares Outstanding of Grace Therapeutics, Inc. from 31 Mar 2018 to 12 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Grace Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Mar 2018 to 12 Feb 2026.
  • Grace Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Feb 2026 was 15,474,026, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Grace Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 15,474,026 +2,057,291 +15% 12 Feb 2026 10-Q 12 Feb 2026 2026 Q3
Q3 2025 15,474,026 +5,334,165 +53% 13 Nov 2025 10-Q/A 17 Nov 2025 2026 Q2
Q2 2025 13,828,562 +4,429,158 +47% 19 Jun 2025 10-K 23 Jun 2025 2025 FY
Q4 2024 13,416,735 +4,017,331 +43% 12 Feb 2025 10-Q/A 19 Feb 2025 2025 Q3
Q3 2024 10,139,861 +740,457 +7.9% 13 Nov 2024 10-Q 13 Nov 2024 2025 Q2
Q2 2024 9,399,404 -35,213,427 -79% 21 Jun 2024 10-K 21 Jun 2024 2024 FY
Q4 2023 9,399,404 -35,213,427 -79% 09 Feb 2024 10-Q 12 Feb 2024 2024 Q3
Q3 2023 9,399,404 -35,213,427 -79% 09 Nov 2023 10-Q 13 Nov 2023 2024 Q2
Q2 2023 44,612,831 +173,073 +0.39% 23 Jun 2023 10-K 23 Jun 2023 2023 FY
Q4 2022 44,612,831 +324,648 +0.73% 13 Feb 2023 10-Q 14 Feb 2023 2022 Q3
Q3 2022 44,612,831 +324,648 +0.73% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q2
Q2 2022 44,439,758 -163,935,791 -79% 21 Jun 2022 10-K 21 Jun 2022 2022 FY
Q4 2021 44,288,183 -135,207,522 -75% 14 Feb 2022 10-Q 14 Feb 2022 2021 Q3
Q3 2021 44,288,183 10 Nov 2021 10-Q 10 Nov 2021 2021 Q2
Q2 2021 208,375,549 +115,887,164 +125% 22 Jun 2021 10-K 22 Jun 2021 2021 FY
Q4 2020 179,495,705 09 Feb 2021 10-Q 09 Feb 2021 2021 Q3
Q2 2020 92,488,385 26 Jun 2020 10-K 29 Jun 2020 2020 FY
Q1 2019 78,132,734 +52,494,519 +205% 31 Mar 2019 20-F 26 Jun 2019 2019 FY
Q1 2018 25,638,215 31 Mar 2018 20-F 29 Jun 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.